.jpg)
.jpg)
IUBMB 2026 September Newsletter
Saturday, 05 September 2026 01:08
2026 SEPTEMBER NEWS A NEW mRNA VACCINE Big news or just hype around a new cancer treatment? Three weeks ago, Merck and Moderna announced what many celebrated. The first mRNA vaccine that proves successful in a phrase 3 Trial. But what do the data say? And how does it work? HELPING YOU DECIDE Is a PhD for you? And if so, what will you encounter? Although this is such an important decision, there is often little guidance available. Our commuincations officer compiled experiences and tips from students and Professors from all over the world. Here are 3 things you must know. WHEN EXPERIMENTAL DATA ISN'T ENOUGH Originally described in the 1880s, its association with homeopathy led scientists to ignore…
Published in
Allgemeine News
FEMS Monthly Newsletter - FEMS MICRO 2027 abstract submissions, CRISPR-Cas webinar, and more
Tuesday, 01 September 2026 11:09
Dear ÖGMBT member, Even as summer draws to a close, there is still plenty happening within the microbiology community. From abstract submissions opening this week for FEMS MICRO 2027 to new journal highlights, upcoming webinar on CRISPR-Cas, and International Microorganism Day taking place this month, there are plenty of ways to read, learn, contribute, and get involved. Take a look below to catch up on the latest news and opportunities from across the FEMS community. Happy reading. The FEMS Team Discover the latest research and publishing opportunities Stay up to date with the latest developments in microbiology through this month's journal highlights. Dive into our new reading list on designing effective phage cocktails, or explore our new thematic issue showcasing the breadth of yeast science emerging from Australia and Aotearoa New Zealand. You can also discover new additions to microLife's must read articles curated to help…
Published in
Allgemeine News
Your FEBS Network highlights - End Aug
Friday, 28 August 2026 04:56
Hello dear ÖGMBT members, Here's a list of the great content selected as a highlight in the past 2 weeks. Trust in scientific publishing cannot be taken for granted Trust underpins scientific publishing, but it cannot be assumed. As the way we produce, discover and consume research evolves, ensuring that rigorous publishing practices remain visible and recogni... Read more Daniela Ruffell FEBS Press Publisher, FEBS Press AKR1C1: a ‘mystery’ enzyme that can catalyse Vitamin B6 metabolism in mammals In a recent study published in The FEBS Journal, researchers identify a new enzyme that can produce metabolically active vitamin B6, thus providing important insights into B6 metabolism and regulat... Read more The FEBS Journal When Cancer Keeps Changing: Can the Immune System Keep Up? As cancer evolves, new mutations can create new targets for the immune system. Could personalised cancer vaccines use these molecular changes to…
Published in
Allgemeine News
